Literature DB >> 22493025

Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome.

L J Moran1, A A Deeks, M E Gibson-Helm, H J Teede.   

Abstract

BACKGROUND: The aim of this study was to assess the psychological features in women with different polycystic ovary syndrome (PCOS) phenotypes [National Institute of Health (NIH) and non-NIH diagnostic criteria] and women without PCOS.
METHODS: An observational, cross-sectional study compared overweight (BMI ≥ 25 kg/m(2)) premenopausal women with PCOS (n = 29 NIH and n = 25 non-NIH) and controls (n = 27). Anxiety and depression were compared between women with NIH or non-NIH PCOS and women without PCOS. Health-related quality of life (HRQoL) domains related to emotions, body hair, weight, infertility and menstrual problems were compared between women with NIH and non-NIH PCOS.
RESULTS: Overall, women with PCOS had worse anxiety (P = 0.007) and depression (P = 0.048) compared with women without PCOS. Both women with NIH PCOS and non-NIH PCOS presented more often with moderate anxiety (P = 0.005 and P = 0.01, respectively) compared with women without PCOS. Women with NIH PCOS had worse HRQoL related to infertility (P = 0.012), emotions (P = 0.02) and weight (P = 0.016). No significant differences were observed between the two PCOS phenotypes for HRQoL domains related to body hair or menstrual problems. Both NIH (β = 0.30, P = 0.024) and non-NIH (β = 0.32, P = 0.016) PCOS status predicted anxiety, whereas age (β = 0.35, P = 0.008) and free androgen index (β = 0.31, P = 0.027) predicted depression.
CONCLUSIONS: PCOS is associated with anxiety and depression. Non-NIH phenotypes present with similar psychological profiles to NIH PCOS, indicating increased psychological dysfunction in PCOS, even in milder reproductive phenotypes. However, women with NIH PCOS appear to have worse HRQoL in some areas than women with non-NIH PCOS. Psychological function and HRQoL should be considered in all women with PCOS.

Entities:  

Mesh:

Year:  2012        PMID: 22493025     DOI: 10.1093/humrep/des114

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  18 in total

Review 1.  Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.

Authors:  Lara C Morley; Thomas Tang; Ephia Yasmin; Robert J Norman; Adam H Balen
Journal:  Cochrane Database Syst Rev       Date:  2017-11-29

2.  How Common are Depressive-Anxiety States, Body Image Concerns and Low Self-Esteem in Patients of PCOS?

Authors:  Rashmi D Joshi; Neena Sawant; Niranjan M Mayadeo
Journal:  J Obstet Gynaecol India       Date:  2021-06-07

Review 3.  Metformin in women with PCOS, cons.

Authors:  Marie L Misso; Helena J Teede
Journal:  Endocrine       Date:  2014-09-02       Impact factor: 3.633

4.  Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome.

Authors:  Abigail Sharpe; Lara C Morley; Thomas Tang; Robert J Norman; Adam H Balen
Journal:  Cochrane Database Syst Rev       Date:  2019-12-17

5.  Physical activity and mental health in women with polycystic ovary syndrome.

Authors:  Lauren K Banting; Melanie Gibson-Helm; Remco Polman; Helena J Teede; Nigel K Stepto
Journal:  BMC Womens Health       Date:  2014-03-27       Impact factor: 2.809

6.  Comparing Sexual Function and Quality of Life in Polycystic Ovary Syndrome and Healthy Women.

Authors:  Vida Shafti; Sara Shahbazi
Journal:  J Family Reprod Health       Date:  2016-06

Review 7.  Polycystic ovary syndrome and mental disorders: a systematic review and exploratory meta-analysis.

Authors:  Sergio Luís Blay; João Vicente Augusto Aguiar; Ives Cavalcante Passos
Journal:  Neuropsychiatr Dis Treat       Date:  2016-11-08       Impact factor: 2.570

Review 8.  Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies.

Authors:  Renae C Fernandez; Vivienne M Moore; Emer M Van Ryswyk; Tamara J Varcoe; Raymond J Rodgers; Wendy A March; Lisa J Moran; Jodie C Avery; R Doug McEvoy; Michael J Davies
Journal:  Nat Sci Sleep       Date:  2018-02-01

Review 9.  Complications and challenges associated with polycystic ovary syndrome: current perspectives.

Authors:  Stefano Palomba; Susanna Santagni; Angela Falbo; Giovanni Battista La Sala
Journal:  Int J Womens Health       Date:  2015-07-31

10.  Efficacy of acupuncture on menstrual frequency in women with polycystic ovary syndrome: Protocol for a randomized, controlled trial.

Authors:  Jing Zhou; Likun Yang; Jinna Yu; Yang Wang; Zhishun Liu
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.